Horn & Co. advised Savoreat Ltd. on the deal. Savoreat Ltd. signed a manufacturing agreement with a well known and veteran American manufacturer. SavorEat Ltd. produces...
You must be a Standard 1 Year member to access this content.
Horn & Co. advised Vascular Biogenics Ltd. on the deal. Vascular Biogenics Ltd. completed the merger with Notable Labs and the sale of its IP assets....
You must be a Standard 1 Year member to access this content.
Horn & Co. advised INX on the deal. INX Digital Company, Inc., a regulated broker-dealer, ATS, and transfer agent based in the US, has reached an...
You must be a Standard 1 Year member to access this content.
Horn advised Scopio Labs on the deal. Scopio Labs completed the collaboration agreement with Siemens Healthineers to Distribute Full-Field Digital Cell Morphology Technology. Scopio Labs provides digital...
You must be a Standard 1 Year member to access this content.
KG advised ENI Plenitude in the deal. ENI Plenitude executed the sale and transfer of the 49% of the shares of Thessaloniki – Thessalia Gas Distribution...
You must be a Standard 1 Year member to access this content.
Horn & Co. advised ART Medical Ltd. on the deal. Teva Israel will market and distribute ART MEDICAL’s ground-breaking smART+ Platform in Israel’s intensive care units....
You must be a Standard 1 Year member to access this content.
Horn & Co. represented VBL Therapeutics on the deal. VBL Therapeutics executed the merger with Notable Labs. The merger aims to create Nasdaq-listed, clinical-stage therapeutic platform company developing new...
You must be a Standard 1 Year member to access this content.
Horn&Co. advised Immunorizon on the deal. Purple Biotech executed the acquisition of Immunorizon in consideration for up to $100 million. Purple Biotech Ltd. is a clinical-stage company...
You must be a Standard 1 Year member to access this content.
Horn & Co. advised Pangea on the deal. Pangea executed a seed investment round. Pangea Biomed is a multi-cancer response predictor improving the effectiveness of precision oncology....
You must be a Standard 1 Year member to access this content.
Horn & Co. advised The INX Digital Company on the deal. The INX Digital Company, Inc. executed a joint venture with SICPA SA in the field...
You must be a Standard 1 Year member to access this content.
Horn & Co. advised Kamari Pharma on the deal. Kamari Pharma executed a joint venture agreement raising $8 million. Kamari Pharma is a biopharmaceutical company that is developing...
You must be a Standard 1 Year member to access this content.
Horn & Co. represented Diagnostic Robotics in the deal, Amit, Pollak, Matalon & Co. advised StageOne, Migdal Insurance, Clal Insurance and Bank Hapoalim on the transaction....
You must be a Standard 1 Year member to access this content.
